Search Results | MRC Clinical Trials Unit at UCL

'25 at 25': The Multi-Arm Multi-Stage (MAMS) design

...reatments with the new MAMS-ROCI design (Podcast) 25 at 25 anniversary highlights

'25 at 25': Individual participant data (IPD) meta-analysis

...ndividual participant data (IPD). As part of our ‘25 at 25’ series to celebrate the Unit’s 25th anniversary, this piece explores how our IPD meta-analyses have influenced the treatment of patients …

'25 at 25': The PRACTical trial design

As part of the MRC Clinical Trials Unit at UCL’s 25th anniversary celebrations, we highlight the Unit’s role in developing new clinical trial designs to address problems where standard trial designs a…

'25 at 25': Shortening treatment for tuberculosis

A long road to recovery lies ahead for people diagnosed with tuberculosis (TB). Treatments lasting several months can be tough for patients due to challenging side effects, the burden of daily medicat…

'25 at 25': Saving lives with early HIV treatment

During the 25th anniversary year of the MRC Clinical Trials Unit at UCL, we celebrate the fact that millions of people with HIV are now living longer, healthier lives thanks to our research. This arti…

'25 at 25': Ovarian cancer screening: The UKCTOCS trial

To celebrate the 25th anniversary of the MRC Clinical Trials Unit and World Cancer Day, we highlight our work throughout the past two decades to help detect ovarian cancer earlier. This article is par…

'25 at 25': Optimising treatments for people with cancer

The cancer trials that hit the headlines tend to be about improving how long people with cancer live or delaying the disease from getting worse. This is obviously very important, particularly for type…